• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

What is the Optimal Dosage of Aspirin to Prevent Preeclampsia?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • There is good evidence that aspirin prevents preeclampsia in women at risk, but there is no agreement on the actual dose
  • In the US, tablets are only available in 81mg and 325mg tablets, while the ASPRE study used 150mg dose
  • Seidler et al. (AJOG 2018) evaluated optimal aspirin dosing for preeclampsia prevention

METHODS:

  • Individual participant data (IPD) from a large meta-analyses of preeclampsia prevention was analyzed and compared to ASPRE findings
  • Exposures
    • ≤81 mg
    • >81 mg
    • Placebo
  • Primary outcomes
    • Preeclampsia
    • Preeclampsia with PTB <37 weeks gestation

RESULTS:

  • 22 previous RCTs, totaling 30,532 women were included
  • Preeclampsia was reduced with aspirin dose ≤ 81 mg relative to placebo
    • Pooled relative risk (RR) 0.92; 95% CI 0.85 – 0.99
  • Greater risk reduction was seen at doses of >81 mg relative to placebo
    • Pooled RR, 0.74; 95% CI, 0.60 – 0.92
    • Similar to results from the ASPRE trial (RR 0.72)
  • For preeclampsia with PTB, a similar pattern was seen
    • 81 mg: IPD pooled RR, 0.86; 95% CI, 0.75-0.98
    • >81 mg: IPD pooled RR, 0.75; 95% CI 0.54-1.04
    • Less effect than seen in ASPRE trial (RR, 0.38)
  • Adjusting for confounding variables did not alter results
  • Among the pooled RCTs, preeclampsia and preeclampsia with PTB declined with increasing aspirin doses, but with overlapping confidence intervals
  • In pooled RCTs that used IPD, the lowest predicted rate of preeclampsia with PTB (1.6%) was observed at a daily dose of 100 mg, the same rate as in the ASPRE trial (1.6%)

CONCLUSION:

  • There is a dose-response effect of aspirin on prevention of preeclampsia and preeclampsia with PTB up to 150 mg daily
  • The authors suggest that a future RCT to compare higher doses such as 150 mg or 162 (double the 81mg tablet) vs 81 mg dose is required and “could benefit millions of pregnant women and their fetuses worldwide at a very low cost and risk”

Learn More – Primary Sources:

Optimal aspirin dosing for preeclampsia prevention

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

When to Introduce Aspirin to Reduce Risks of Preeclampsia?
Aspirin Treatment for Women at Risk for Preeclampsia – ACOG, SMFM and USPSTF Recommendations
ASPRE Trial: A Combined Risk Algorithm and Use of Aspirin to Prevent Preterm Preeclampsia

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site